- Projects & figures
- News & Events
- Managing your project
- About ERC
An ERC-funded project has significantly increased understanding of the crucial role that microorganisms in the gut play in maintaining health. The findings have since led to a patent, as well as a follow-on project that could one day steer the way to new targeted treatments for diseases, including cancer.
An ERC-funded project is conducting groundbreaking research into a rare form of leukaemia, proving the effectiveness in patients of non-chemotherapy-based treatments that target the genetic cause of the disease. The Hairy Cell Leukemia project, launched by the Institute of Hematology at the University of Perugia in Italy with funding from the European Research Council, is one of the world’s foremost initiatives to develop a targeted therapy for hairy cell leukaemia (HCL), a rare form of blood cancer.
Assisted Reproductive Technology (ART) is increasingly used to help women become pregnant. The most common technique is in vitro fertilisation, i.e. the transfer of fertilised human eggs into a woman's uterus. However, ART can imply risks for the embryo during the pregnancy or even later in life. With a grant of the European Research Council (ERC), Polish researcher Dr Grazyna Ewa Ptak has analysed sheeps embryos. With her team at the University of Teramo, she has discovered the precise timing and nature of placental disorders consequent to ART. Her findings can greatly improve reproductive technologies and lead to safer pregnancies for both women and animals.